Question - What are the cardiovascular toxic effects of the so-called immune checkpoint inhibitors (pembrolizumab, nivolumab, ipilmumab)?
Answer - Myocarditis is the cardiovascular toxic effect of the so- called immune checkpoint inhibitors (pembrolizumab, nivolumab, ipilmumab). (Moslehi JJ. Cardiovascular toxic effects of targeted cancer therapy. 2016 NEJM 375: 1457-1467)
Posted in Question Of The Day